Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dashan Ai

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 31, 2022
Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trialZhi Zhang, Jinjun Ye, Hui Li, et al.
The Oncologist|June 7, 2023
Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective TrialsIhsuan Tseng, Fangfang Li, Dashan Ai, et al.
Thoracic Cancer|March 14, 2023
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020Hongcheng Zhu, Zezhou Wang, Bingbin Deng, et al.
British Journal of Cancer|December 26, 2025
PD-1 inhibitor improves radiosensitivity by tumor vessel normalizationShengnan Hao, Dashan Ai, Quanxin Wang, et al.
The Oncologist|January 4, 2021
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)Li Chu, Yun Chen, Qi Liu, et al.
Journal of Thoracic Disease|May 17, 2023
Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapyBing Xu, Ihsuan Tseng, Xiaofei Zhang, et al.
Radiation Oncology (London, England)|February 8, 2023
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)Dashan Ai, Yun Chen, Qi Liu, et al.
Radiation Oncology (London, England)|October 19, 2023
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organsIhsuan Tseng, Dashan Ai, Yun Chen, et al.
IEEE Transactions on Medical Imaging|June 9, 2026
From Slice to Sequence: Autoregressive Tracking Transformer for Consistent 3D Lymph Node Detection in CT ScansQinji Yu, Yirui Wang, Ke Yan, et al.
Clinical and Translational Radiation Oncology|January 14, 2026
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trialsJingyi Shen, Dashan Ai, Yun Chen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 31, 2022
Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trialZhi Zhang, Jinjun Ye, Hui Li, et al.
The Oncologist|June 7, 2023
Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective TrialsIhsuan Tseng, Fangfang Li, Dashan Ai, et al.
Thoracic Cancer|March 14, 2023
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020Hongcheng Zhu, Zezhou Wang, Bingbin Deng, et al.
British Journal of Cancer|December 26, 2025
PD-1 inhibitor improves radiosensitivity by tumor vessel normalizationShengnan Hao, Dashan Ai, Quanxin Wang, et al.
The Oncologist|January 4, 2021
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)Li Chu, Yun Chen, Qi Liu, et al.
Journal of Thoracic Disease|May 17, 2023
Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapyBing Xu, Ihsuan Tseng, Xiaofei Zhang, et al.
Radiation Oncology (London, England)|February 8, 2023
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)Dashan Ai, Yun Chen, Qi Liu, et al.
Radiation Oncology (London, England)|October 19, 2023
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organsIhsuan Tseng, Dashan Ai, Yun Chen, et al.
IEEE Transactions on Medical Imaging|June 9, 2026
From Slice to Sequence: Autoregressive Tracking Transformer for Consistent 3D Lymph Node Detection in CT ScansQinji Yu, Yirui Wang, Ke Yan, et al.
Clinical and Translational Radiation Oncology|January 14, 2026
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trialsJingyi Shen, Dashan Ai, Yun Chen, et al.
Pageof 3